Literature DB >> 8200549

Cytochrome P450 expression in oesophageal cancer.

G I Murray1, D Shaw, R J Weaver, J A McKay, S W Ewen, W T Melvin, M D Burke.   

Abstract

The cytochrome P450 superfamily of enzymes play a central part in the metabolism of carcinogens and anti-cancer drugs. The expression, cellular localisation, and distribution of different forms of P450 and the functionally associated enzymes epoxide hydrolase and glutathione S-transferases have been investigated in oesophageal cancer and non-neoplastic oesophageal tissue using immunohistochemistry. Expression of the different enzymes was confined to epithelial cells in both non-neoplastic samples and tumour samples except the CYP3A was also identified in mast cells and glutathione S-transferase pi was present in chronic inflammatory cells. CYP1A was present in a small percentage of non-neoplastic samples but both CYP2C and CYP3A were absent. Epoxide hydrolase was present in half of the non-neoplastic samples and the different classes of glutathione S-transferase were present in a low number of samples. In carcinomas CYP1A, CYP3A, epoxide hydrolase, and glutathione S-transferase pi were expressed in at least 60% of samples. The expression of glutathione S-transferases alpha and mu were significantly less in adenocarcinoma compared with squamous carcinoma.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8200549      PMCID: PMC1374739          DOI: 10.1136/gut.35.5.599

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  27 in total

Review 1.  Metabolic activation of carcinogens.

Authors:  F P Guengerich
Journal:  Pharmacol Ther       Date:  1992       Impact factor: 12.310

Review 2.  The P450 superfamily: update on new sequences, gene mapping, accession numbers, early trivial names of enzymes, and nomenclature.

Authors:  D R Nelson; T Kamataki; D J Waxman; F P Guengerich; R W Estabrook; R Feyereisen; F J Gonzalez; M J Coon; I C Gunsalus; O Gotoh
Journal:  DNA Cell Biol       Date:  1993 Jan-Feb       Impact factor: 3.311

Review 3.  Roles of cytochrome P-450 enzymes in chemical carcinogenesis and cancer chemotherapy.

Authors:  F P Guengerich
Journal:  Cancer Res       Date:  1988-06-01       Impact factor: 12.701

4.  Expression of xenobiotic metabolizing enzymes in breast cancer.

Authors:  G I Murray; R J Weaver; P J Paterson; S W Ewen; W T Melvin; M D Burke
Journal:  J Pathol       Date:  1993-03       Impact factor: 7.996

Review 5.  Molecular properties and biological functions of microsomal epoxide hydrase.

Authors:  A Y Lu; G T Miwa
Journal:  Annu Rev Pharmacol Toxicol       Date:  1980       Impact factor: 13.820

6.  Xenobiotic metabolising enzyme expression in colonic neoplasia.

Authors:  J A McKay; G I Murray; R J Weaver; S W Ewen; W T Melvin; M D Burke
Journal:  Gut       Date:  1993-09       Impact factor: 23.059

Review 7.  Glutathione transferases and cancer.

Authors:  S Tsuchida; K Sato
Journal:  Crit Rev Biochem Mol Biol       Date:  1992       Impact factor: 8.250

8.  Cytochrome P450 2C9 is responsible for hydroxylation of the naphthoquinone antimalarial drug 58C80 in human liver.

Authors:  R J Weaver; M Dickins; M D Burke
Journal:  Biochem Pharmacol       Date:  1993-10-05       Impact factor: 5.858

9.  The expression of cytochrome P-450, epoxide hydrolase, and glutathione S-transferase in hepatocellular carcinoma.

Authors:  G I Murray; P J Paterson; R J Weaver; S W Ewen; W T Melvin; M D Burke
Journal:  Cancer       Date:  1993-01-01       Impact factor: 6.860

10.  Identification of rifampin-inducible P450IIIA4 (CYP3A4) in human small bowel enterocytes.

Authors:  J C Kolars; P Schmiedlin-Ren; J D Schuetz; C Fang; P B Watkins
Journal:  J Clin Invest       Date:  1992-11       Impact factor: 14.808

View more
  18 in total

1.  Triterpenoid resinous metabolites from the genus Boswellia: pharmacological activities and potential species-identifying properties.

Authors:  Yuxin Zhang; Zhangchi Ning; Cheng Lu; Siyu Zhao; Jianfen Wang; Baoqin Liu; Xuegong Xu; Yuanyan Liu
Journal:  Chem Cent J       Date:  2013-09-12       Impact factor: 4.215

2.  Phase I/II enzyme gene polymorphisms and esophageal cancer risk: a meta-analysis of the literature.

Authors:  Chun-Xia Yang; Keitaro Matsuo; Zhi-Ming Wang; Kazuo Tajima
Journal:  World J Gastroenterol       Date:  2005-05-07       Impact factor: 5.742

3.  CYP1A1 and CYP2E1 genotypes and risk of esophageal squamous cell carcinoma in a high-incidence region, Kashmir.

Authors:  Gulzar Ahmad Bhat; Idrees Ayoub Shah; Muzamil Ashraf Makhdoomi; Beenish Iqbal; Rumaisa Rafiq; Sumaiya Nabi; Akbar Masood; Mohd Maqbool Lone; Nazir Ahmad Dar
Journal:  Tumour Biol       Date:  2014-02-08

4.  Cytochrome P450 levels are altered in patients with esophageal squamous-cell carcinoma.

Authors:  I Bergheim; E Wolfgarten; E Bollschweiler; A-H Hölscher; C Bode; A Parlesak
Journal:  World J Gastroenterol       Date:  2007-02-21       Impact factor: 5.742

Review 5.  Update information on drug metabolism systems--2009, part II: summary of information on the effects of diseases and environmental factors on human cytochrome P450 (CYP) enzymes and transporters.

Authors:  S Rendic; F P Guengerich
Journal:  Curr Drug Metab       Date:  2010-01       Impact factor: 3.731

6.  Mutation and protein expression analysis of CYP1A1 gene-a study on female breast cancer cases from India.

Authors:  Mohammad Zeeshan Najm; Salman Akhtar; Istaq Ahmad; Shilpi Chattopadhyay; Nasar Mallick; Sarah Siddiqui; Shuaib Zaidi; Waseem Ahmad Siddiqui; Syed Akhtar Husain
Journal:  Tumour Biol       Date:  2013-10-07

7.  Expression patterns of carcinogen detoxifying genes (CYP1A1, GSTP1 & GSTT1) in HNC patients.

Authors:  Nosheen Masood; Mahmood Akhtar Kayani
Journal:  Pathol Oncol Res       Date:  2012-08-25       Impact factor: 3.201

8.  Enhanced expression of cytochrome P450 in stomach cancer.

Authors:  G I Murray; M C Taylor; M D Burke; W T Melvin
Journal:  Br J Cancer       Date:  1998-04       Impact factor: 7.640

Review 9.  Cytochrome P450 CYP1A1: wider roles in cancer progression and prevention.

Authors:  Vasilis P Androutsopoulos; Aristidis M Tsatsakis; Demetrios A Spandidos
Journal:  BMC Cancer       Date:  2009-06-16       Impact factor: 4.430

10.  Antiproliferative and cytostatic effects of the natural product eupatorin on MDA-MB-468 human breast cancer cells due to CYP1-mediated metabolism.

Authors:  Vasilis Androutsopoulos; Randolph R J Arroo; John F Hall; Somchaiya Surichan; Gerry A Potter
Journal:  Breast Cancer Res       Date:  2008-05-02       Impact factor: 6.466

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.